Parker Waichman LLP Files Plavix Lawsuits on Behalf of Victims who Suffered Life-Threatening Bleeding Side Effects Allegedly Due to Plavix

Share Article

Lawsuits Allege Use of Plavix Caused Serious Gastrointestinal Bleeding and Other Life-Threatening Bleeding Side Effects, Including Cerebral Hemorrhage and Thrombotic Thrombocytopenic Purpura

PW Logo

Parker Waichman LLP, a national law firm representing people injured by defective drugs, has filed several new lawsuits on behalf of individuals allegedly injured by life-threatening Plavix bleeding side effects. Three complaints filed on May 3, 2012, in the Supreme Court of the State of New York, County of New York, allege use of Plavix caused Plaintiffs to suffer serious gastrointestinal bleeds (Index Nos. 152380/2012; 152381/2012; and 152382/2012).

Parker Waichman LLP filed an additional six Plavix bleeding lawsuits on April 30, 2012, also in the Supreme Court of the State of New York, County of New York. Those complaints allege use of Plavix caused Plaintiffs to suffer from a number of bleeding side effects, including gastrointestinal hemorrhage, cerebral hemorrhage and a blood condition called thrombotic thrombocytopenic purpura (TTP). (Index Nos. 152244/2012; 152232/2012; 152253/2012; 152234/2012; 152238/2012; and 152250/2012).

Plavix, a blood thinner known generically as clopidogrel, was first approved by the U.S. Food and Drug Administration (FDA) in 1997 for the prevention of heart attack and stroke. According to the Plavix lawsuits filed by Parker Waichman LLP, the Defendants falsely touted the drug as being more effective and safer in reducing the risk of ischemic events compared to a less expensive daily aspirin regimen. By 2005, Plavix was the sixth top selling drug in the U.S. and the Defendants enjoy annual sales of Plavix totaling 3.8 billion dollars, the complaints state.

Each of the lawsuits alleges that users of Plavix are at a greatly increased risk of serious, dangerous, and potentially fatal side effects including heart attack, stroke, internal bleeding, blood disorder and/or death. The complaints further allege that use of the drug caused severe personal injuries which are permanent and lasting in nature, physical pain and mental anguish, including diminished enjoyment of life, as well as the need for lifelong medical treatment, monitoring and/or medications, and fear of developing other health consequences.

Among other things, the complaints allege that Bristol-Myers Squibb and Sanofi-Aventis negligently and/or fraudulently represented to the medical and healthcare community, the FDA, the Plaintiffs and the public in general, that Plavix had been tested and was found to be safe and/or effective for its indicated use. The lawsuits further charge that the Defendants concealed their knowledge of Plavix defects from the Plaintiffs, the FDA, the public in general and/or the medical community specifically.

For more information regarding Plavix bleeding side effects, please view this video blog produced by Parker Waichman LLP.

Parker Waichman LLP continues to offer free legal consultations to victims of alleged Plavix side effects, including:

  •     Cerebral hemorrhage
  •     Thrombotic Thrombocytopenic Purpura (TTP)
  •     Gastrointestinal bleeding
  •     Ulcers
  •     Internal bleeding
  •     Bone marrow damage
  •     Heart attack
  •     Stroke
  •     Death

If you or a loved experienced serious, life-threatening internal bleeding, heart attacks, strokes, or a blood disorder, and you believe Plavix is to blame, please contact their office by visiting the firm's Plavix side effects page at Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

For more information regarding Plavix side effects lawsuits and Parker Waichman LLP, please visit: or call 1-800-LAW-INFO (1-800-529-4636).

Parker Waichman LLP
Gary Falkowitz, Managing Attorney
(800) LAW-INFO
(800) 529-4636

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Herb Waichman, Partner
Parker Waichman LLP
(800) 529-4636
Email >
Visit website